Page last updated: 2024-11-04

tegafur and Bile Duct Obstruction

tegafur has been researched along with Bile Duct Obstruction in 8 studies

Research Excerpts

ExcerptRelevanceReference
"A total of 123 patients with unresectable or recurrent gastric adenocarcinoma with peritoneal metastasis receiving intravenous and intraperitoneal paclitaxel combined with S-1 were retrospectively studied."3.78Role of intervention for biliary and gastric/intestinal obstruction in gastric cancer with peritoneal metastasis. ( Emoto, S; Hirano, K; Isayama, H; Ishigami, H; Kawakubo, K; Kitayama, J; Kogure, H; Koike, K; Nakai, Y; Sasahira, N; Sasaki, T; Tada, M; Yamaguchi, H; Yamamoto, N, 2012)
"We report a case of recurrent gastric cancer that responded significantly to the short-term administration of TS-1."1.31[Case report: a recurrent gastric cancer in the terminal stage, associated with obstructive jaundice which responded significantly to oral administration of TS-1]. ( Fukuda, H; Sugihara, Z; Tasaka, K; Tomofuzi, Y, 2001)
"Multiple liver and lung metastasis of breast cancer were diagnosed because of high CA 15/3 serum levels and normal gastrointestinal study."1.30[Effective chemo-endocrine combination therapy for obstructive-jaundice caused by multiple liver metastasis of recurrent breast cancer--a case report]. ( Hoshino, K; Ikeda, H; Koyama, T; Morishita, Y; Nakamura, M, 1999)
"One year after total gastrectomy due to gastric cancer, the 50-year-old male patient underwent lateral segmentectomy, since metastatic foci occurred in the outer region of the liver."1.28[A case of biliary tract obstruction due to metastatic hepatic cancer, in which topical injection of CDDP and ADM into PTCD with concomitant use of UFT resulting in partial reopening of biliary tract]. ( Hayashi, T; Kitagawa, S; Nakagawa, M; Yamada, T, 1989)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's1 (12.50)18.2507
2000's3 (37.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakai, Y1
Ishigami, H1
Isayama, H1
Sasaki, T1
Kawakubo, K1
Kogure, H2
Emoto, S1
Yamaguchi, H1
Kitayama, J1
Yamamoto, N1
Sasahira, N1
Hirano, K1
Tada, M1
Koike, K1
Arai, W1
Hosoya, Y1
Hyodo, M1
Yokoyama, T1
Saito, S1
Kurasina, K1
Aoki, T1
Yasuda, Y1
Nagai, H1
Tamada, K1
Yajima, T1
Furukawa, Y1
Ishii, Y1
Hattori, Y1
Matsumoto, N1
Yamamoto, M1
Yamaoka, Y1
Fujihara, M1
Fujita, M1
Kuniki, H1
Hoshino, K1
Nakamura, M1
Ikeda, H1
Koyama, T1
Morishita, Y1
Tasaka, K1
Tomofuzi, Y1
Sugihara, Z1
Fukuda, H1
Hayashi, T1
Yamada, T1
Kitagawa, S1
Nakagawa, M1
Tomita, T1
Tajima, T1
Ishibashi, M1
Tagaya, N1
Aoki, H1
Itoh, S1
Kadowaki, A1
Tajima, Y1
Shioda, Y1
Koizumi, S1
Furuya, S1
Tokunaga, A1
Tanaka, N1
Onda, M1

Other Studies

8 other studies available for tegafur and Bile Duct Obstruction

ArticleYear
Role of intervention for biliary and gastric/intestinal obstruction in gastric cancer with peritoneal metastasis.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Drainage;

2012
[Every-other-day TS-1 administration for recurrent or non-curative advanced gastric carcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:9

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring C

2002
[Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cholestasis; Deoxycytidine; Drug Ad

2004
[Effective chemo-endocrine combination therapy for obstructive-jaundice caused by multiple liver metastasis of recurrent breast cancer--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:7

    Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla

1999
[Case report: a recurrent gastric cancer in the terminal stage, associated with obstructive jaundice which responded significantly to oral administration of TS-1].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:10

    Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Cholestasis; Drug Combi

2001
[A case of biliary tract obstruction due to metastatic hepatic cancer, in which topical injection of CDDP and ADM into PTCD with concomitant use of UFT resulting in partial reopening of biliary tract].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Ducts, Intrahepatic; Catheters, Indwelling; Cho

1989
[Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile; Biliary Tract Neoplasms; Cholestasis; Fe

1989
[Two cases of obstructive jaundice due to advanced gastric cancer with marked response to the intravenous administration of cisplatinum].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:8

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cholestasis; Cisplatin; Female

1988